2007-18年风疹流行病学:监测数据的生态学分析
疫苗不合格队列的绝对和比例发病率均高于合格队列。疫苗接种成功降低了风疹负担,但育龄妇女仍面临风险,尤其在未引入疫苗的国家。
要点
- 疫苗不合格队列发病率高于合格队列,87%病例为15岁以下儿童。
- 未引入疫苗国家的育龄妇女风险更高,应尽快引入含风疹疫苗。
核心结论
- 疫苗接种成功降低了风疹负担,无论采用何种策略。
- 育龄妇女仍面临风疹风险,未引入疫苗的国家风险更高。
- 这些国家应尽快引入含风疹疫苗以消除风疹并预防先天性风疹综合征(CRS)相关发病和死亡。
研究设计与样本
- 生态学分析,评估2007年1月1日至2018年12月31日向WHO报告的风疹病例监测数据。
- 病例按年龄、疫苗接种史和发病年份分析,并根据国家疫苗接种策略和出生年份分类为疫苗合格或不不合格。
- 仅纳入实验室确诊或流行病学关联病例,排除仅临床诊断病例;发病率使用World Population Prospects数据计算。
主要发现
- 所有年份疫苗不合格队列的绝对和比例全球发病率均高于合格队列。
- 除2011-12年外,疫苗不合格育龄妇女发病率高于疫苗合格育龄妇女。
临床怎么用
- 未引入含风疹疫苗的国家应尽快引入疫苗以消除风疹和预防CRS。
- 监测应关注育龄妇女的风疹风险,尤其是疫苗不合格人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As of 2018, the rubella vaccine had been incorporated into the national immunisation schedule of 168 countries, representing 87% of the world's population. Countries have used different strategies to reduce the burden of congenital rubella syndrome (CRS), such as vaccinating only females. Given the different strategies, and that 26 countries still had not introduced the vaccine, we analysed global rubella surveillance data to understand rubella epidemiology and the effect of vaccination. METHODS: In this ecological analysis, we evaluated surveillance data on rubella cases that had been reported to WHO from 2007 to 2018, by age, vaccination history, and onset year. Cases were classified as either being vaccine eligible or ineligible on the basis of the country's vaccination strategy and the birth year of the person. We required all cases be confirmed by laboratory testing or that they were epidemiologically linked, and we excluded cases defined only by clinical symptoms. Incidence per million people was calculated by use of World Population Prospects data. FINDINGS: Between Jan 1, 2007, and Dec 31, 2018, from data reported to WHO as of Jan 3, 2020, there were 139 486 reported rubella cases, of which 15 613 (11%) were vaccine eligible. Annual incidence ranged from 13·9 cases per million in 2007 to 1·7 cases per million in 2018. In all years, absolute and proportional global incidence were higher among vaccine ineligible cohorts than eligible cohorts. In vaccine ineligible cohorts, 87 666 (74%) of 118 308 cases were in children younger than 15 years, compared with 8423 (54%) of 15 613 cases in vaccine eligible cohorts. Vaccine ineligible women of reproductive age (WRA) had a higher incidence than vaccine eligible WRA, except in 2011-12. INTERPRETATION: Vaccination has been successful in decreasing the burden of rubella, regardless of the strategy used. WRA remain at risk, but the risk is higher in those countries that have yet to introduce the vaccine. These countries should introduce the rubella-containing vaccine as soon as possible, to eliminate rubella, and to prevent the morbidity and mortality associated with CRS. FUNDING: None.
引用
- Patel MK, Antoni S, Danovaro-Holliday MC, et al. The epidemiology of rubella, 2007-18: an ecological analysis of surveillance data. Lancet Glob Health. 2020. PMID: 33069300. doi:10.1016/S2214-109X(20)30320-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。